NF-κB: Ten Years After
暂无分享,去创建一个
[1] S. Grimm,et al. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis , 1996, The Journal of cell biology.
[2] T. Maniatis,et al. Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.
[3] H. Pahl,et al. Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention , 1996, The Journal of cell biology.
[4] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[5] P. Sigler,et al. Structure of NF-κB p50 homodimer bound to a κB site , 1998, Nature.
[6] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[7] A. Strasser,et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.
[8] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[9] M. Jung,et al. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. , 1995, Science.
[10] H. Erdjument-Bromage,et al. IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.
[11] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[12] F. Weih,et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.
[13] Gregory L. Verdine,et al. Structure of the NF-κB p50 homodimer bound to DNA , 1995, Nature.
[14] P. Baeuerle,et al. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.
[15] P. Baeuerle,et al. Failure of the splicing variant p65 delta of the NF-kappa B subunit p65 to transform fibroblasts. , 1994, Oncogene.
[16] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[17] B. Vandenbunder,et al. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro , 1993, Cell.
[18] G. Nolan,et al. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.
[19] V. Bours,et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.
[20] S. Ruben,et al. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.
[21] S. Ruben,et al. Identification of a Naturally Occurring Transforming Variant of the p65 Subunit of NF-KB , 1992, Science.
[22] U. Zabel,et al. Purified I kappa B-beta is inactivated upon dephosphorylation. , 1992, The Journal of biological chemistry.
[23] G. Nabel,et al. Cloning of RкB, a novel DNA-binding protein that recognizes the interleukin-2 receptor α chain кB site: New Biol. 3, 1063–1073 , 1992 .
[24] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. , 1991, Cell.
[25] U. Zabel,et al. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA , 1990, Cell.
[26] D. Baltimore,et al. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.
[27] D. Baltimore,et al. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.
[28] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[29] A. Strasser,et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.
[30] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[31] P. Baeuerle,et al. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.
[32] G. Nolan,et al. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.
[33] V. Bours,et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.
[34] D. Baltimore,et al. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.
[35] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.